Assays for the identification and evaluation of histone acetyltransferase inhibitors

被引:35
作者
Aherne, GW [1 ]
Rowlands, MG [1 ]
Stimson, L [1 ]
Workman, P [1 ]
机构
[1] Inst Canc Res, Canc Res UK Ctr Canc Therapeut, Sutton SM2 5NG, Surrey, England
关键词
histone acetyltransferase; histone deacetylase; gene transcription; chromatin; cancer; high-throughput screening; histone acetyltransferase inhibitors; enzyme-linked immunoassay;
D O I
10.1016/S1046-2023(02)00028-2
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
There is presently enormous interest in the function and regulatory roles of histone acetyltransferase enzymes. Along with deacetylases it is now evident that these enzymes play a key role in many cellular processes including chromatin remodeling and gene transcription. As such, effective small molecule enzyme inhibitors would be useful tools for molecular pharmacology and may also be suitable for further development into agents for the treatment of diseases such as cancer, A high-throughput assay based on the use of scintillating microplates (FlashPlates) suitable for screening libraries of compounds for inhibitors of acetylase activity is described here. Confirmation of activity of selected compounds is achieved with a conventional filter assay, the details of which are also described. In addition, an assay suitable for confirming that cellular protein acetylation has been altered by inhibition of acetylases or deacetylases is also presented. On the same plate, cells are grown, exposed to compound, fixed, and permeabilized, and protein acetylation is determined using standard ELISA methodology and a europium-labeled second antibody. This latter method provides a medium-throughput alternative to the use of immunoblotting for mechanistic studies. (C) 2002 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:245 / 253
页数:9
相关论文
共 71 条
[1]  
AHERNE GW, 2002, ANTI-CANCER DRUG DES, P249
[2]   A rapid and sensitive assay for histone acetyl-transferase activity [J].
Ait-Si-Ali, S ;
Ramirez, S ;
Robin, P ;
Trouche, D ;
Harel-Bellan, A .
NUCLEIC ACIDS RESEARCH, 1998, 26 (16) :3869-3870
[3]   Histone acetyltransferase activity of CBP is controlled by cycle-dependent kinases and oncoprotein E1A [J].
Ait-Si-Ali, S ;
Ramirez, S ;
Barre, FX ;
Dkhissi, F ;
Magnaghi-Jaulin, L ;
Girault, JA ;
Robin, P ;
Knibiehler, M ;
Pritchard, LL ;
Ducommun, B ;
Trouche, D ;
Harel-Bellan, A .
NATURE, 1998, 396 (6707) :184-186
[4]   AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer [J].
Anzick, SL ;
Kononen, J ;
Walker, RL ;
Azorsa, DO ;
Tanner, MM ;
Guan, XY ;
Sauter, G ;
Kallioniemi, OP ;
Trent, JM ;
Meltzer, PS .
SCIENCE, 1997, 277 (5328) :965-968
[5]   The CBP co-activator is a histone acetyltransferase [J].
Bannister, AJ ;
Kouzarides, T .
NATURE, 1996, 384 (6610) :641-643
[6]   Regulation of gene expression by transcription factor acetylation [J].
Bannister, AJ ;
Miska, EA .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2000, 57 (8-9) :1184-1192
[7]   Gene regulation - Local or global? [J].
Berger, SL .
NATURE, 2000, 408 (6811) :412-415
[8]   The translocation t(8;l6)(p11, p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB binding protein [J].
Borrow, J ;
Stanton, VP ;
Andresen, JM ;
Becher, R ;
Behm, FG ;
Chaganti, RSK ;
Civin, CI ;
Disteche, C ;
Dube, I ;
Frischauf, AM ;
Horsman, D ;
Mitelman, F ;
Volinia, S ;
Watmore, AE ;
Housman, DE .
NATURE GENETICS, 1996, 14 (01) :33-41
[9]   AN ACTIVITY GEL ASSAY DETECTS A SINGLE, CATALYTICALLY ACTIVE HISTONE ACETYLTRANSFERASE SUBUNIT IN TETRAHYMENA MACRONUCLEI [J].
BROWNELL, JE ;
ALLIS, CD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (14) :6364-6368
[10]   Requirement for TAFII250 acetyltransferase activity in cell cycle progression [J].
Dunphy, EL ;
Johnson, T ;
Auerbach, SS ;
Wang, EH .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (04) :1134-1139